Why experts project a boom in healthcare M&A activity in 2025
Factors like lower inflation and interest rate cuts make 2025 a good year for getting deals done.
Factors like lower inflation and interest rate cuts make 2025 a good year for getting deals done.
Pharma companies have warned that the lowered prices will mean less drug innovation.
Advocacy group and bipartisan letters urged the FDA to take action and pull the ad from running during Sunday’s game.
The retail chain started the council as a way to boost pharmacy school enrollment and address some industrywide issues.
Total investment dollars more than tripled between 2023 and 2024, according to an SVB analysis.
The fast-lane approval process has raised concerns about oversight.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.